ERBB2 and breast carcinoma: Of all 15 TN breast cancers that were included in this study, e.g. ER-PR-Her2-, respectively 7 biopsies (P = 0.091) and 12 primary tumor specimens (P = 0.008) showed a positive FRα expression.